Healthcare SPAC LifeSci Acquisition sets terms for $50 million IPO
LifeSci Acquisition, a blank check company targeting healthcare industry, announced terms for its IPO on Friday.
The New York, NY-based company plans to raise $50 million by offering 5 million units at a price of $10 and would command a market value of $63 million. Each unit consists of one share of common stock and one warrant exercisable at $11.50.
LifeSci Acquisition was founded in 2018 and plans to list on the Nasdaq under the symbol LSACU. Chardan Capital Markets is the sole bookrunner on the deal.
The article Healthcare SPAC LifeSci Acquisition sets terms for $50 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.